Page last updated: 2024-11-07

dehydroepiandrosterone and Myofascial Trigger Point Pain

dehydroepiandrosterone has been researched along with Myofascial Trigger Point Pain in 1 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pradeep, A1
Birerdinc, A1
Branigan, T1
Phan, V1
Morris, H1
Shah, J1
DeStefano, S1
Sikdar, S1
Srbely, J1
Kumbhare, D1
Stecco, A1
Paik, J1
Gerber, LH1

Other Studies

1 other study available for dehydroepiandrosterone and Myofascial Trigger Point Pain

ArticleYear
Evidence for an association of serum microanalytes and myofascial pain syndrome.
    BMC musculoskeletal disorders, 2023, Aug-01, Volume: 24, Issue:1

    Topics: Acetylcholine; Adult; Brain-Derived Neurotrophic Factor; Cytokines; Dehydroepiandrosterone; Female;

2023